Bacterial Co-infections in Mucormycosis in Severely Ill Populations: an Overlooked and Complex Challenge
Overview
Overview
Authors
Affiliations
Affiliations
Soon will be listed here.
Abstract
Mucormycosis is found in co-infection with bacteria in >50% of the cases. Most of these cases were reported among people with haematological diseases. The two most frequent bacteria found were and . Almost 40% of the identified bacteria were reported as multidrug resistant.
References
1.
Yang S, Anikst V, Adamson P
. Endofungal Mycetohabitans rhizoxinica Bacteremia Associated with Rhizopus microsporus Respiratory Tract Infection. Emerg Infect Dis. 2022; 28(10):2091-2095.
PMC: 9514336.
DOI: 10.3201/eid2810.220507.
View
2.
Cheok K, Farrow A, Springell D, OReilly M, Morley S, Stone N
. Mucormycosis after CD19 chimeric antigen receptor T-cell therapy: results of a US Food and Drug Administration adverse events reporting system analysis and a review of the literature. Lancet Infect Dis. 2024; 24(4):e256-e265.
DOI: 10.1016/S1473-3099(23)00563-7.
View
3.
Magiorakos A, Srinivasan A, Carey R, Carmeli Y, Falagas M, Giske C
. Multidrug-resistant, extensively drug-resistant and pandrug-resistant bacteria: an international expert proposal for interim standard definitions for acquired resistance. Clin Microbiol Infect. 2011; 18(3):268-81.
DOI: 10.1111/j.1469-0691.2011.03570.x.
View
4.
Chakrabarti A, Das A, Mandal J, Shivaprakash M, George V, Tarai B
. The rising trend of invasive zygomycosis in patients with uncontrolled diabetes mellitus. Med Mycol. 2006; 44(4):335-42.
DOI: 10.1080/13693780500464930.
View
5.
Partida-Martinez L, Groth I, Schmitt I, Richter W, Roth M, Hertweck C
. Burkholderia rhizoxinica sp. nov. and Burkholderia endofungorum sp. nov., bacterial endosymbionts of the plant-pathogenic fungus Rhizopus microsporus. Int J Syst Evol Microbiol. 2007; 57(Pt 11):2583-2590.
DOI: 10.1099/ijs.0.64660-0.
View